| Page 1215 | Kisaco Research
MemCon 2023 Draft Agenda
 

Patricia Doykos

Executive Director, Health Equity –Global Health Equity & Policy Partnerships
Bristol Myers Squibb

Patricia “Patti” Mae Doykos is the inaugural executive director for Health Equity at Bristol Myers Squibb. She has responsibility for the company’s $150M Health Equity Commitments as well as a number of domestic and global health partnerships. Embedding a health equity lens in everything BMS does is an opportunity to expand and improve the quality of the company’s science and the reach and impact of its innovative medicines on patients, particularly for medically underserved and increasingly diverse patient populations and journeys.  

 

Patricia Doykos

Executive Director, Health Equity –Global Health Equity & Policy Partnerships
Bristol Myers Squibb

Patricia Doykos

Executive Director, Health Equity –Global Health Equity & Policy Partnerships
Bristol Myers Squibb

Patricia “Patti” Mae Doykos is the inaugural executive director for Health Equity at Bristol Myers Squibb. She has responsibility for the company’s $150M Health Equity Commitments as well as a number of domestic and global health partnerships. Embedding a health equity lens in everything BMS does is an opportunity to expand and improve the quality of the company’s science and the reach and impact of its innovative medicines on patients, particularly for medically underserved and increasingly diverse patient populations and journeys.  

 

Patti has over 25 years of experience and leadership in transformative corporate philanthropy and corporate social responsibility, product brand and strategic communications, and health equity and social justice from her roles in the company and the Bristol Myers Squibb Foundation. She has developed and led US and international grant-making and public-private partnership programs for global HIV/AIDS, women’s health, diabetes, cancer, serious mental illness, cardiovascular disease, immunology and COVID19. Among her current service roles are inaugural chair of the board of the Center for Global Health Equity at Dartmouth-Geisel Medical School, Board of Advisors for Dartmouth-Geisel Medical School, Advisory Board for the Center for Global Health at Rutgers University, and Trustee of Phillips Academy Andover and member of its Anti-Racism Task Force.

Adrian Spillmann

Great topics and high quality speakers. Not to forget about the great networking opportunities f2f. I truly enjoyed the event. 

Adrian Spillmann

Great topics and high quality speakers. Not to forget about the great networking opportunities face to face. I truly enjoyed the event. 

Aude Veinante

It is always great to attend conferences wherein both in house and law firm speakers are there, in addition when we can get generic and innovators views

 

Jungmin Kim

Vice President
Pood

Jungmin Kim

Vice President
Pood

Jungmin Kim

Vice President
Pood
 

Wachirawit Siridachanon

Co-Founder and CFO
SOPet

Wachirawit Siridachanon

Co-Founder and CFO
SOPet

Wachirawit Siridachanon

Co-Founder and CFO
SOPet
 

Heather Bessoff

CEO
Aptimmune Biologics

Heather Bessoff

CEO
Aptimmune Biologics

Heather Bessoff

CEO
Aptimmune Biologics
 

Jonathan Bester

Founder and CEO
Peptobiotics

Jonathan Bester

Founder and CEO
Peptobiotics

Jonathan Bester

Founder and CEO
Peptobiotics
 

Ms. Claire Pribula

Managing Director
The Yield Lab Asia Pacific

Ms. Claire Pribula

Managing Director
The Yield Lab Asia Pacific

Ms. Claire Pribula

Managing Director
The Yield Lab Asia Pacific